In this study, we found that treating OVA-AAI mice with LY294002 significantly inhibited NLRP3 inflammasome activity in lung tissue, which is consistent with the PI3K–NLRP3 chain of action reported in asthma.11 This evidence concerns the gene NLRP3 and asthma.